
501 - 1000 employees
Founded 2013
๐งฌ Biotechnology
๐ Pharmaceuticals
๐ฅ Healthcare
๐ฐ $78.3M Post IPO equity on 2025-07
Biotechnology โข Pharmaceuticals โข Healthcare
Alvotech is a biopharmaceutical company that specializes in developing and manufacturing biosimilarsโbiologic medicines highly similar to approved reference biologicsโto increase global patient access to affordable biologic therapies. The company follows a vertically integrated approach, covering cell line development through fill-and-finish manufacturing, and partners with commercialization experts to bring products to market. Its pipeline includes proposed biosimilars to high-profile biologics, and it emphasizes scale, control and speed in production. Alvotech operates globally and focuses on improving access to biologic medicines.
๐ก We watch Alvotech's careers page
Every 2 hours
how often we check
5
roles posted in the last 30 days
Selected: ๐ Date Added.
๐ฅ 1 hour ago
Analytical Scientist supporting analytical development and physicochemical characterization of monoclonal antibodies and other biological products. Reviewing data, validating methods, and preparing scientific reports in India.
๐ฎ๐ณ India โ Remote
๐ฐ $78.3M Post IPO equity on 2025-07
โฐ Full Time
๐ก Mid-level
๐ Senior
โจ Scientist
๐ป Ghost score 15%
๐ฅ 1 hour ago
Analytical Scientist supporting bioassay development, validation, and characterization of biopharmaceutical products. Reviewing analytical data and authoring scientific and regulatory documentation from an India home office.
๐ฎ๐ณ India โ Remote
๐ฐ $78.3M Post IPO equity on 2025-07
โฐ Full Time
๐ก Mid-level
๐ Senior
โจ Scientist
๐ป Ghost score 15%
๐ October 20
Director optimizing global biosimilar forecasts, supply allocation, and commercial business cases. Partnering across commercial, finance, supply chain, and business development teams.
๐บ๐ธ United States โ Remote
๐ฐ $78.3M Post IPO equity on 2025-07
โฐ Full Time
๐ด Lead
๐ Director
๐ป Ghost score 15%
๐ October 16
Director leading statistical and data management programming for Alvotechโs biosimilar medicines. Establishing standards, overseeing SDTM/ADaM deliverables, and guiding regulatory submissions.
๐ธ๐ช Sweden โ Remote
๐ฐ $78.3M Post IPO equity on 2025-07
โฐ Full Time
๐ด Lead
๐ Director
๐ป Ghost score 15%